CClinicalTrials.gg
CompletedNCT02363465Updated Oct 6, 2015

Echographic Measurement of Skin Thickness

An observational study in Skin Thickness, sponsored by Novosanis NV. Completed at 1 site in Belgium. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-10-06.

Sponsored by Novosanis NV · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
100
Ages
18 Years to 65 Years
Sex
All
01

Study summary

To optimize a medical device for intradermal injection, knowledge concerning the thickness of epidermis and dermis at the proximal forearm is required. Since scientific knowledge is lacking, the investigators will examine the skin thickness (epidermis and dermis) of adults using imaging technology (High Frequency Ultrasound). The investigators hypothesize that they are able to correlate the thickness of the (epi)dermis to a specific combination of parameters age, gender, and BMI.

Based on these results, the investigators can define which needle type and length is needed to correctly perform injections into the dermal layer.

02

Conditions studied

  • Skin Thickness

Keywords

  • skin thickness
  • high-frequency ultrasound
03

In context

Lead sponsor

Novosanis NV is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Participants will be recruited in the vicinity of the university and its university hospital of Antwerp, in the period of January 2015 until April 2015.

Inclusion criteria

  • Healthy adults
  • Age: 18-65 years
  • Dutch-speaking
  • Caucasian

Exclusion criteria

Exclusion Criteria:

  • Pregnancy or lactating
  • Using ointment, crème, or gels based on corticoids
  • Suffering from skin diseases (psoriasis, burning wounds)
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
100 participants (actual)
Patient registry
No

Groups and cohorts

  • Participants aged 18-30 years

    Echographic measurement of skin thickness at the proximal forearm and the deltoid region in participants aged 18-30 years. aimed number: 12 male \& 12 female maximum number: 15 male \& 15 female

    Other: Echographic measurement of skin thickness

  • Participants aged 31-40 years

    Echographic measurement of skin thickness at the proximal forearm and the deltoid region in participants aged 31-40 years. aimed number: 12 male \& 12 female maximum number: 15 male \& 15 female

    Other: Echographic measurement of skin thickness

  • Participants aged 41-50 years

    Echographic measurement of skin thickness at the proximal forearm and the deltoid region in participants aged 41-50 years. aimed number: 12 male \& 12 female maximum number: 15 male \& 15 female

    Other: Echographic measurement of skin thickness

  • Participants aged 51-65 years

    Echographic measurement of skin thickness at the proximal forearm and the deltoid region in participants aged 51-65 years. aimed number: 12 male \& 12 female maximum number: 15 male \& 15 female

    Other: Echographic measurement of skin thickness

Interventions

  • OtherEchographic measurement of skin thickness

    (Epi)Dermal thickness at the proximal forearm and the deltoid region will be measured using imaging technology, more specifically high-frequency ultrasound (20-40 MHz) in B-mode (VEVO 2100®, Visual Sonics). This non-invasive measuring technique has already been proven to be accurate. The echographic measurement will be performed on the left and right deltoid region and on two sides of the proximal forearm. Both the dorsal part and the volar/palmar part of the proximal forearm will be investigated. Ultrasound will be executed using gel (Aquasonic®) to optimize imaging.

06

What researchers measure

Primary outcomes

  1. skin thickness (in milimeters) of the proximal forearm dorsal (both left and right)

    Time frame: 10 minutes

  2. skin thickness (in milimeters) of the proximal forearm ventral (both left and right)

    Time frame: 10 minutes

  3. skin thickness (in milimeters) of the deltoid region (both left and right)

    Time frame: 10 minutes

Secondary outcomes

  1. Body Mass Index

    Time frame: at the moment of entering the study

  2. Age

    Time frame: at the moment of entering the study

  3. sex

    Time frame: at the moment of entering the study

07

Study locations

1 site
  • Department of Pharmaceutical Sciences; Laboratory of Physiopharmacology; University of Antwerp; Campus Drie Eiken
    Wilrijk, Antwerp 2610, Belgium
08

References and documents

Publications

  • Van Mulder TJ, de Koeijer M, Theeten H, Willems D, Van Damme P, Demolder M, De Meyer G, Beyers KC, Vankerckhoven V. High frequency ultrasound to assess skin thickness in healthy adults. Vaccine. 2017 Mar 27;35(14):1810-1815. doi: 10.1016/j.vaccine.2016.07.039. Epub 2016 Aug 3. PubMed 27496276 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 6, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02363465
Lead sponsor
Novosanis NV
Responsible party
Sponsor
First posted
Feb 16, 2015
Start date
Jan 2015
Primary completion
Jun 2015
Completion
Jun 2015
Last update
Oct 6, 2015

Study contacts

Vanessa Vankerckhoven, PhD
principal investigator · CEO

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion